Inoue T - Search Results

1

Acute renal failure associated with minimal change nephrotic syndrome in an elderly adult.

Morita A, Ishimura E, Tabata T, Shoji S, Inoue T, Nishizawa Y, Morii H. Morita A, et al. Among authors: inoue t. Osaka City Med J. 1994 Jul;40(1):37-42. Osaka City Med J. 1994. PMID: 9309942

2

Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Emoto M, et al. Among authors: inoue t. Nephron. 1992;61(2):181-6. doi: 10.1159/000186868. Nephron. 1992. PMID: 1630543

3

Acute renal failure in McArdle's disease.

Tabata T, Kikunami K, Matsushita Y, Inoue T, Inoue T, Okamoto T, Kono N, Takahashi M, Tarui S, Morii H. Tabata T, et al. Among authors: inoue t. Nephron. 1986;44(4):371-4. doi: 10.1159/000184023. Nephron. 1986. PMID: 3467218

4

A case of B cell lymphoma complicated by hypercalcemia and acute renal insufficiency.

Morii H, Ohnishi Y, Okamoto T, Nishizawa Y, Miki T, Iba K, Wada M, Inoue T, Matsushita Y, Kikunami K, et al. Morii H, et al. Among authors: inoue t. Osaka City Med J. 1983;29(1):75-85. Osaka City Med J. 1983. PMID: 6610155 No abstract available.

5

The effect of oral 1 alpha-hydroxycalciferol treatment on bone mineral density in hemodialysis patients.

Morita A, Tabata T, Inoue T, Nishizawa Y, Morii H. Morita A, et al. Among authors: inoue t. Clin Nephrol. 1996 Dec;46(6):389-93. Clin Nephrol. 1996. PMID: 8982555

6

History of vitamin D treatment of renal osteodystrophy.

Morii H, Ishimura E, Inoue T, Tabata T, Morita A, Nishii Y, Fukushima M. Morii H, et al. Among authors: inoue t. Am J Nephrol. 1997;17(3-4):382-6. doi: 10.1159/000169125. Am J Nephrol. 1997. PMID: 9189258

7

Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.

Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H. Shoji T, et al. Among authors: inoue t. Atherosclerosis. 1997 Jun;131(2):229-36. doi: 10.1016/s0021-9150(97)00054-3. Atherosclerosis. 1997. PMID: 9199276

8

A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.

Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Morita A, et al. Among authors: inoue t. Clin Nephrol. 1992 Sep;38(3):154-7. Clin Nephrol. 1992. PMID: 1395169

9

Effects of dietary phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatment.

Tabata T, Shoji S, Morita A, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Tabata T, et al. Among authors: inoue t. J Nutr Sci Vitaminol (Tokyo). 1991 Dec;37 Suppl:S105-12. doi: 10.3177/jnsv.37.supplement_s105. J Nutr Sci Vitaminol (Tokyo). 1991. PMID: 1820436

10

Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.

Miki T, Nakatsuka K, Nishizawa Y, Emoto M, Morita A, Tabata T, Matsushita Y, Inoue T, Morii H. Miki T, et al. Among authors: inoue t. Endocrinol Jpn. 1991 Oct;38(5):479-83. doi: 10.1507/endocrj1954.38.479. Endocrinol Jpn. 1991. PMID: 1843267 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,900 results

Search Page

Filters